A review of treatment for retinopathy of prematurity

Introduction: Retinopathy of prematurity (ROP) is a leading cause of childhood blindness worldwide. Areas covered: Recent methods to identify and manage treatment-warranted vascularly active ROP are recognized and being compared to standard care by laser treatment in prospective large-scale clinical...

Celý popis

Uloženo v:

Podrobná bibliografie
Vydáno v:	Expert review of ophthalmology Ročník 14; číslo 2; s. 73 - 87
Hlavní autoři:	Hansen, Eric D., Hartnett, M. Elizabeth
Médium:	Journal Article
Jazyk:	angličtina
Vydáno:	England Taylor & Francis 04.03.2019
Témata:	angiogenesis laser lens-sparing retinal detachment Retinopathy of prematurity (ROP) scleral buckle stage 4 or 5 ROP surgical outcomes vascular endothelial growth factor inhibitors (anti-VEGF) vitrectomy lens-sparing retinopathy of prematurity (ROP) laser surgical outcomes angiogenesis vascular endothelial growth factor inhibitors (anti-VEGF) vitrectomy scleral buckle retinal detachment stage 4 or 5 ROP
ISSN:	1746-9899, 1746-9902
On-line přístup:	Získat plný text
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!

Abstract	Introduction: Retinopathy of prematurity (ROP) is a leading cause of childhood blindness worldwide. Areas covered: Recent methods to identify and manage treatment-warranted vascularly active ROP are recognized and being compared to standard care by laser treatment in prospective large-scale clinical studies. Pharmacologic anti-angiogenic (anti-VEGF) treatment has changed the natural history of vascularly active ROP by reducing stage 3 intravitreal neovascularization and extending physiologic retinal vascularization in many infants. Tractional retinal detachments in stage 4 ROP after treatment with anti-VEGF agents show additional fibrovascular complexity compared to eyes treated with laser only. We review current management and outcomes for vascularly active and fibrovascular retinal detachment in ROP (stages 3, 4, 5 ROP), highlighting the evidence from recent clinical studies. Included are technical details important in surgery for retinal detachment in ROP. Literature searches were employed through PubMed. Expert opinion: Experimental studies in basic mechanisms, methods in pediatric imaging, safer pharmacologic treatments, and surgical techniques continue to advance to improve future ROP outcomes.
AbstractList	Retinopathy of prematurity (ROP) is a leading cause of childhood blindness worldwide.INTRODUCTIONRetinopathy of prematurity (ROP) is a leading cause of childhood blindness worldwide.Recent methods to identify and manage treatment-warranted vascularly active ROP are recognized and being compared to standard care by laser treatment in prospective large-scale clinical studies. Pharmacologic anti-angiogenic (anti-VEGF) treatment has changed the natural history of vascularly active ROP by reducing stage 3 intravitreal neovascularization and extending physiologic retinal vascularization in many infants. Tractional retinal detachments in stage 4 ROP after treatment with anti-VEGF agents show additional fibrovascular complexity compared to eyes treated with laser only. We review current management and outcomes for vascularly active and fibrovascular retinal detachment in ROP (stages 3, 4, 5 ROP), highlighting the evidence from recent clinical studies. Included are technical details important in surgery for retinal detachment in ROP. Literature searches were employed through PubMed.AREAS COVEREDRecent methods to identify and manage treatment-warranted vascularly active ROP are recognized and being compared to standard care by laser treatment in prospective large-scale clinical studies. Pharmacologic anti-angiogenic (anti-VEGF) treatment has changed the natural history of vascularly active ROP by reducing stage 3 intravitreal neovascularization and extending physiologic retinal vascularization in many infants. Tractional retinal detachments in stage 4 ROP after treatment with anti-VEGF agents show additional fibrovascular complexity compared to eyes treated with laser only. We review current management and outcomes for vascularly active and fibrovascular retinal detachment in ROP (stages 3, 4, 5 ROP), highlighting the evidence from recent clinical studies. Included are technical details important in surgery for retinal detachment in ROP. Literature searches were employed through PubMed.Methods in pediatric imaging, safer pharmacologic treatments, and surgical techniques continue to advance to improve future ROP outcomes.EXPERT OPINIONMethods in pediatric imaging, safer pharmacologic treatments, and surgical techniques continue to advance to improve future ROP outcomes. Retinopathy of prematurity (ROP) is a leading cause of childhood blindness worldwide. Recent methods to identify and manage treatment-warranted vascularly active ROP are recognized and being compared to standard care by laser treatment in prospective large-scale clinical studies. Pharmacologic anti-angiogenic (anti-VEGF) treatment has changed the natural history of vascularly active ROP by reducing stage 3 intravitreal neovascularization and extending physiologic retinal vascularization in many infants. Tractional retinal detachments in stage 4 ROP after treatment with anti-VEGF agents show additional fibrovascular complexity compared to eyes treated with laser only. We review current management and outcomes for vascularly active and fibrovascular retinal detachment in ROP (stages 3, 4, 5 ROP), highlighting the evidence from recent clinical studies. Included are technical details important in surgery for retinal detachment in ROP. Literature searches were employed through PubMed. Methods in pediatric imaging, safer pharmacologic treatments, and surgical techniques continue to advance to improve future ROP outcomes. Introduction: Retinopathy of prematurity (ROP) is a leading cause of childhood blindness worldwide. Areas covered: Recent methods to identify and manage treatment-warranted vascularly active ROP are recognized and being compared to standard care by laser treatment in prospective large-scale clinical studies. Pharmacologic anti-angiogenic (anti-VEGF) treatment has changed the natural history of vascularly active ROP by reducing stage 3 intravitreal neovascularization and extending physiologic retinal vascularization in many infants. Tractional retinal detachments in stage 4 ROP after treatment with anti-VEGF agents show additional fibrovascular complexity compared to eyes treated with laser only. We review current management and outcomes for vascularly active and fibrovascular retinal detachment in ROP (stages 3, 4, 5 ROP), highlighting the evidence from recent clinical studies. Included are technical details important in surgery for retinal detachment in ROP. Literature searches were employed through PubMed. Expert opinion: Experimental studies in basic mechanisms, methods in pediatric imaging, safer pharmacologic treatments, and surgical techniques continue to advance to improve future ROP outcomes.
Author	Hartnett, M. Elizabeth Hansen, Eric D.
AuthorAffiliation	1 John A. Moran Eye Center, University of Utah, Salt Lake City, USA
AuthorAffiliation_xml	– name: 1 John A. Moran Eye Center, University of Utah, Salt Lake City, USA
Author_xml	– sequence: 1 givenname: Eric D. surname: Hansen fullname: Hansen, Eric D. organization: John A. Moran Eye Center, University of Utah – sequence: 2 givenname: M. Elizabeth surname: Hartnett fullname: Hartnett, M. Elizabeth email: me.hartnett@hsc.utah.edu organization: John A. Moran Eye Center, University of Utah
BackLink	https://www.ncbi.nlm.nih.gov/pubmed/31762784$$D View this record in MEDLINE/PubMed
BookMark	eNqFUUtPGzEQthAVJIGfQJUjl6S2d-OHKlWgqFAkJC5wtia7Y3C1a6e2A8q_r1dJUNsDPc1o5nuM5huTYx88EnLB6JxRRb8wWQuttJ5zyvScLbSgXByR0TCfaU358aEvoFMyTuknpYtK1fyEnFZMCi5VPSL19TTiq8O3abDTHBFyjz5PbYhlnp0Pa8gv22G5jthD3kSXt2fkk4Uu4fm-TsjTzffH5Y_Z_cPt3fL6ftbUSuYZR6lWLQhsWaWQ21UlYQXSMtk2CMgEowtZCQZWNVYpzRQIK1veNqytNFfVhHzb6a43qx4LyecInVlH10PcmgDO_L3x7sU8h1cjlKw5p0Xgci8Qw68Npmx6lxrsOvAYNsnw8ggtZK0Gr89_er2bHF5VAF93gCaGlCJa07gM2YXB2nWGUTMEYw7BmCEYsw-msBf_sA8G_-Nd7XjOl0x6eAuxa02GbReijeAbl8qJH0r8Bpb9pdA
CitedBy_id	crossref_primary_10_1007_s00417_022_05730_6 crossref_primary_10_1167_iovs_66_6_61 crossref_primary_10_1002_jbt_22641 crossref_primary_10_1089_hum_2022_079 crossref_primary_10_7759_cureus_76000 crossref_primary_10_1016_j_pdpdt_2021_102658 crossref_primary_10_1007_s10792_021_02095_3 crossref_primary_10_3389_fmed_2021_761398 crossref_primary_10_18502_jovr_v19i2_14027 crossref_primary_10_1167_iovs_62_3_2 crossref_primary_10_3389_fmed_2022_969861 crossref_primary_10_3390_cells13161371 crossref_primary_10_2147_OPTH_S443810 crossref_primary_10_5409_wjcp_v12_i4_220 crossref_primary_10_1007_s10462_025_11153_6 crossref_primary_10_1038_s42003_024_07394_w crossref_primary_10_1186_s12886_025_04397_x crossref_primary_10_3390_electronics9091444 crossref_primary_10_1016_j_survophthal_2025_03_006 crossref_primary_10_7759_cureus_56168 crossref_primary_10_1002_jbt_22572 crossref_primary_10_2147_JMDH_S539699 crossref_primary_10_3345_cep_2021_00773 crossref_primary_10_3390_children11080927 crossref_primary_10_1097_ICB_0000000000001220 crossref_primary_10_1038_s41598_024_57072_4 crossref_primary_10_1016_j_preteyeres_2025_101392 crossref_primary_10_1038_s41433_024_03563_7 crossref_primary_10_3928_23258160_20250412_01 crossref_primary_10_1038_s41433_021_01679_8
Cites_doi	10.1016/j.survophthal.2018.04.002 10.1016/j.ophtha.2016.04.028 10.1001/jamaophthalmol.2014.1604 10.1016/j.ophtha.2014.12.017 10.1001/archopht.120.5.595 10.5409/wjcp.v7.i1.62 10.1542/peds.2008-2697 10.1371/journal.pone.0148019 10.1001/archophthalmol.2009.361 10.1007/s10456-018-9618-5 10.1016/j.ophtha.2017.09.020 10.1001/archopht.1984.01040030908011 10.1136/bjophthalmol-2017-311345 10.1542/peds.2015-3218 10.1016/S0161-6420(01)01015-6 10.1001/archophthalmol.2010.72 10.1016/j.jpeds.2010.01.046 10.1001/jamapediatrics.2017.4838 10.1053/j.ajkd.2016.12.011 10.1016/S0161-6420(90)32506-X 10.1007/BF02343046 10.1016/j.ajo.2007.01.017 10.1097/00006982-200306000-00006 10.1097/IAE.0000000000000667 10.1097/IAE.0000000000001209 10.1016/j.ajo.2009.05.027 10.1542/peds.2004-1413 10.1001/archopht.123.7.991 10.1016/S0042-6989(97)88335-6 10.1016/0002-9394(54)90845-4 10.1097/IAE.0b013e3181610f97 10.1016/j.jaapos.2013.01.004 10.1001/archopht.1992.01080140140042 10.1073/pnas.0805817105 10.1016/S0008-4182(03)80090-X 10.1097/IAE.0000000000001719 10.1016/j.ophtha.2016.06.055 10.1097/IAE.0000000000000771 10.1097/00006982-200404000-00008 10.1167/iovs.12-9516 10.1016/j.ajo.2008.10.006 10.3928/0191-3913-19930101-08 10.1001/archophthalmol.2010.65 10.1016/j.ophtha.2004.06.021 10.1371/journal.pone.0003554 10.3928/23258160-20170630-06 10.1038/nm1591 10.1016/S0161-6420(01)00809-0 10.1136/bjo.38.7.397 10.1097/IAE.0000000000001685 10.1056/NEJMoa1007374 10.1097/ICU.0b013e328309f1a5 10.1016/S0161-6420(87)33255-5 10.1016/S0021-5155(03)00088-1 10.1001/archopht.124.1.24 10.1016/S0161-6420(94)31362-5 10.1016/S0140-6736(95)92475-2 10.2353/ajpath.2007.061237 10.1016/j.ophtha.2014.11.004 10.1001/archophthalmol.2011.229 10.1016/S0161-6420(85)34038-1 10.1097/IAE.0000000000000604 10.1016/S0161-6420(90)32637-4 10.1007/s10384-015-0401-5 10.1016/S0161-6420(03)00831-5 10.1001/jamaophthalmol.2017.2195 10.1097/00006982-200104000-00001 10.1016/j.ophtha.2016.04.033 10.1016/j.ophtha.2018.11.001 10.1016/j.ophtha.2004.05.030 10.1136/archdischild-2016-310532 10.1172/JCI17808 10.1001/jamaophthalmol.2014.2772 10.1097/IAE.0000000000001725 10.1016/S0161-6420(79)35436-7 10.3928/1542-8877-20000901-04 10.1001/jamaophthalmol.2017.1055 10.1097/IAE.0000000000000128 10.1001/archophthalmol.2012.592 10.1016/j.jpeds.2018.10.033 10.1016/S0161-6420(92)31978-5 10.1023/A:1022474120512 10.1016/j.earlhumdev.2007.11.009 10.1016/S0140-6736(12)61856-X 10.1056/NEJMra1208129 10.1038/nm1095-1024 10.1016/j.ajo.2006.05.048 10.1097/IAE.0b013e31815e986c 10.1016/S0161-6420(01)01017-X 10.1136/bjophthalmol-2014-305561 10.1097/00006982-200410000-00011 10.1097/IAE.0000000000002172 10.1016/j.ophtha.2017.11.009 10.1001/archopht.1993.01090030063040 10.1001/jamaophthalmol.2017.2069 10.1097/01.iae.0000244286.56133.09 10.1097/ICU.0000000000000360 10.1097/ICB.0000000000000221 10.1073/pnas.0702031104 10.1016/j.ophtha.2014.07.050 10.1038/s41598-018-20278-4 10.1016/j.jaapos.2012.10.025 10.1136/bjophthalmol-2016-309198 10.1097/IAE.0b013e3182993d5f 10.1016/j.jaapos.2008.02.001 10.1001/archopht.1988.01060130517027 10.1542/peds.2018-3061 10.1016/j.ophtha.2005.03.031 10.1056/NEJM199204163261603 10.1097/01.iae.0000244257.60524.89 10.1097/IAE.0000000000001779 10.1136/bjophthalmol-2011-301353 10.1159/000330174 10.1016/j.ajo.2011.07.005
ContentType	Journal Article
Copyright	2019 Informa UK Limited, trading as Taylor & Francis Group 2019
Copyright_xml	– notice: 2019 Informa UK Limited, trading as Taylor & Francis Group 2019
DBID	AAYXX CITATION NPM 7X8 5PM
DOI	10.1080/17469899.2019.1596026
DatabaseName	CrossRef PubMed MEDLINE - Academic PubMed Central (Full Participant titles)
DatabaseTitle	CrossRef PubMed MEDLINE - Academic
DatabaseTitleList	MEDLINE - Academic PubMed
Database_xml	– sequence: 1 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: 7X8 name: MEDLINE - Academic url: https://search.proquest.com/medline sourceTypes: Aggregation Database
DeliveryMethod	fulltext_linktorsrc
Discipline	Medicine
EISSN	1746-9902
EndPage	87
ExternalDocumentID	PMC6874220 31762784 10_1080_17469899_2019_1596026 1596026
Genre	Review Journal Article
GrantInformation_xml	– fundername: National Eye Institute Vision Core grantid: NEI Core grant EY014800 to the Department of Opht,NEI R01EY107011,NEI R13EY029900,NEI T35EY026511,NEIR01EY015130,unrestricted grant from Research to Prevent Blindn funderid: 10.13039/100000053 – fundername: NEI NIH HHS grantid: P30 EY014800 – fundername: NEI NIH HHS grantid: R13 EY029900 – fundername: NEI NIH HHS grantid: R01 EY017011 – fundername: NEI NIH HHS grantid: T35 EY026511 – fundername: NEI NIH HHS grantid: R01 EY015130
GroupedDBID	--- 0R~ 29G 4.4 53G 5GY 7X7 AAOUU AAWTL ABEIZ ABJNI ABJXJ ABLKL ABXYU ACGFS AECIN AEOZL AESAV AFRVT AGDLA AGMLL AHMBA AIJEM AIRBT AIYSM AKBVH ALMA_UNASSIGNED_HOLDINGS ALQZU AQTUD BLEHA CCCUG CS3 EBS EJD F5P H13 HZ~ IAO IEA IHR INR KYCEM LJTGL M4Z MV1 O9- P2P RNANH TASJS TBQAZ TDBHL TFL TFW TUROJ AAYXX CITATION 0BK 3V. 8AO 8FI 8FJ AAGSP ABKMU ABUWG ACNPW ADBBV AFKRA ALIPV BENPR BPHCQ BVXVI CCPQU FYUFA HMCUK INH ITC NPM OVD PQQKQ PROAC RFE TEORI UKHRP 7X8 5PM
ID	FETCH-LOGICAL-c487t-2e78bda6ed138e2fb37aba7f17dceae161057361af8cf88918a6f7d2dc1d39283
IEDL.DBID	TFW
ISICitedReferencesCount	34
ISICitedReferencesURI	http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000470063900001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
ISSN	1746-9899
IngestDate	Tue Nov 04 01:52:28 EST 2025 Fri Sep 05 11:57:23 EDT 2025 Thu Jan 02 22:55:12 EST 2025 Tue Nov 18 22:12:20 EST 2025 Sat Nov 29 06:17:37 EST 2025 Mon Oct 20 23:49:19 EDT 2025
IsPeerReviewed	true
IsScholarly	true
Issue	2
Keywords	lens-sparing retinopathy of prematurity (ROP) laser surgical outcomes angiogenesis vascular endothelial growth factor inhibitors (anti-VEGF) vitrectomy scleral buckle retinal detachment stage 4 or 5 ROP
Language	English
LinkModel	DirectLink
MergedId	FETCHMERGED-LOGICAL-c487t-2e78bda6ed138e2fb37aba7f17dceae161057361af8cf88918a6f7d2dc1d39283
Notes	ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23
PMID	31762784
PQID	2317967488
PQPubID	23479
PageCount	15
ParticipantIDs	crossref_citationtrail_10_1080_17469899_2019_1596026 pubmed_primary_31762784 crossref_primary_10_1080_17469899_2019_1596026 pubmedcentral_primary_oai_pubmedcentral_nih_gov_6874220 informaworld_taylorfrancis_310_1080_17469899_2019_1596026 proquest_miscellaneous_2317967488
PublicationCentury	2000
PublicationDate	2019-03-04
PublicationDateYYYYMMDD	2019-03-04
PublicationDate_xml	– month: 03 year: 2019 text: 2019-03-04 day: 04
PublicationDecade	2010
PublicationPlace	England
PublicationPlace_xml	– name: England
PublicationTitle	Expert review of ophthalmology
PublicationTitleAlternate	Expert Rev Ophthalmol
PublicationYear	2019
Publisher	Taylor & Francis
Publisher_xml	– name: Taylor & Francis
References	CIT0072 CIT0071 CIT0073 CIT0076 CIT0075 CIT0078 CIT0077 CIT0110 CIT0070 CIT0112 CIT0115 CIT0114 CIT0117 CIT0116 CIT0119 CIT0118 CIT0083 CIT0082 CIT0085 CIT0084 CIT0120 CIT0086 CIT0001 CIT0089 CIT0122 CIT0088 Zilis JD (CIT0100) 1990; 97 CIT0121 McColm JR (CIT0013) 2004; 10 CIT0081 CIT0080 Roohipoor R (CIT0087) 2009; 4 CIT0003 CIT0002 CIT0123 CIT0005 CIT0125 CIT0007 CIT0006 CIT0009 CIT0008 CIT0094 CIT0093 CIT0096 CIT0095 CIT0010 CIT0098 CIT0097 CIT0012 CIT0011 CIT0099 CIT0092 CIT0091 CIT0014 CIT0016 CIT0015 CIT0018 CIT0019 CIT0021 CIT0020 CIT0023 CIT0022 Chen J (CIT0030) 2008; 118 CIT0025 CIT0024 CIT0027 CIT0026 CIT0029 CIT0028 CIT0032 Chuang YC (CIT0079) 2000; 31 CIT0031 CIT0033 Yeo DCM (CIT0090) 2018; 7 Maguire AM (CIT0074) 1993; 30 Flynn JT (CIT0017) 1987; 105 CIT0036 CIT0035 CIT0038 CIT0037 CIT0039 Coats DK (CIT0069) 2005; 103 CIT0041 CIT0040 CIT0043 CIT0042 CIT0045 CIT0044 Dobson V (CIT0111) 1995; 36 Darlow BA (CIT0113) 2018; 102 CIT0047 CIT0046 CIT0049 CIT0048 CIT0050 CIT0052 CIT0051 CIT0054 CIT0053 CIT0056 CIT0055 Blencowe H (CIT0004) 2016; 53 Saito Y (CIT0034) 2007; 13 CIT0058 CIT0057 CIT0059 CIT0061 CIT0060 CIT0063 CIT0062 CIT0065 CIT0064 CIT0067 CIT0066 CIT0109 CIT0102 Carvalho Recchia C (CIT0124) 2005 CIT0068 CIT0101 CIT0104 CIT0103 CIT0106 CIT0105 CIT0108 CIT0107
References_xml	– ident: CIT0003 doi: 10.1016/j.survophthal.2018.04.002 – ident: CIT0049 doi: 10.1016/j.ophtha.2016.04.028 – ident: CIT0123 doi: 10.1001/jamaophthalmol.2014.1604 – volume: 10 start-page: 512 year: 2004 ident: CIT0013 publication-title: Mol Vis – ident: CIT0051 doi: 10.1016/j.ophtha.2014.12.017 – volume: 13 start-page: 840 year: 2007 ident: CIT0034 publication-title: Mol Vis – ident: CIT0039 doi: 10.1001/archopht.120.5.595 – ident: CIT0088 doi: 10.5409/wjcp.v7.i1.62 – volume: 4 start-page: 185 issue: 3 year: 2009 ident: CIT0087 publication-title: J Ophthalmic Vis Res – ident: CIT0011 doi: 10.1542/peds.2008-2697 – ident: CIT0059 doi: 10.1371/journal.pone.0148019 – ident: CIT0068 doi: 10.1001/archophthalmol.2009.361 – ident: CIT0022 doi: 10.1007/s10456-018-9618-5 – volume: 36 start-page: 692 issue: 3 year: 1995 ident: CIT0111 publication-title: Invest Ophthalmol Vis Sci – ident: CIT0122 doi: 10.1016/j.ophtha.2017.09.020 – ident: CIT0016 doi: 10.1001/archopht.1984.01040030908011 – volume: 102 start-page: 1041 issue: 8 year: 2018 ident: CIT0113 publication-title: Br J Ophthalmol doi: 10.1136/bjophthalmol-2017-311345 – ident: CIT0060 doi: 10.1542/peds.2015-3218 – ident: CIT0042 doi: 10.1016/S0161-6420(01)01015-6 – ident: CIT0020 doi: 10.1001/archophthalmol.2010.72 – ident: CIT0010 doi: 10.1016/j.jpeds.2010.01.046 – ident: CIT0046 doi: 10.1001/jamapediatrics.2017.4838 – ident: CIT0037 doi: 10.1053/j.ajkd.2016.12.011 – ident: CIT0076 doi: 10.1016/S0161-6420(90)32506-X – ident: CIT0086 doi: 10.1007/BF02343046 – ident: CIT0084 doi: 10.1016/j.ajo.2007.01.017 – volume: 105 start-page: 906 year: 1987 ident: CIT0017 publication-title: The Classification of Retinal Detachment Arch Ophthalmol – ident: CIT0063 doi: 10.1097/00006982-200306000-00006 – ident: CIT0093 doi: 10.1097/IAE.0000000000000667 – ident: CIT0058 doi: 10.1097/IAE.0000000000001209 – ident: CIT0085 doi: 10.1016/j.ajo.2009.05.027 – ident: CIT0038 doi: 10.1542/peds.2004-1413 – ident: CIT0025 doi: 10.1001/archopht.123.7.991 – ident: CIT0112 doi: 10.1016/S0042-6989(97)88335-6 – ident: CIT0007 doi: 10.1016/0002-9394(54)90845-4 – ident: CIT0106 doi: 10.1097/IAE.0b013e3181610f97 – volume: 103 start-page: 281 year: 2005 ident: CIT0069 publication-title: Trans Am Ophthalmol Soc – ident: CIT0053 doi: 10.1016/j.jaapos.2013.01.004 – ident: CIT0073 doi: 10.1001/archopht.1992.01080140140042 – ident: CIT0036 doi: 10.1073/pnas.0805817105 – ident: CIT0080 doi: 10.1016/S0008-4182(03)80090-X – ident: CIT0072 doi: 10.1097/IAE.0000000000001719 – ident: CIT0054 doi: 10.1016/j.ophtha.2016.06.055 – ident: CIT0092 doi: 10.1097/IAE.0000000000000771 – ident: CIT0070 doi: 10.1097/00006982-200404000-00008 – ident: CIT0056 doi: 10.1167/iovs.12-9516 – ident: CIT0071 doi: 10.1016/j.ajo.2008.10.006 – volume: 30 start-page: 28 year: 1993 ident: CIT0074 publication-title: J Pediatr Ophthalmol Strabismus doi: 10.3928/0191-3913-19930101-08 – ident: CIT0055 doi: 10.1001/archophthalmol.2010.65 – ident: CIT0104 doi: 10.1016/j.ophtha.2004.06.021 – ident: CIT0121 doi: 10.1371/journal.pone.0003554 – ident: CIT0005 doi: 10.3928/23258160-20170630-06 – ident: CIT0035 doi: 10.1038/nm1591 – ident: CIT0067 doi: 10.1016/S0161-6420(01)00809-0 – ident: CIT0014 doi: 10.1136/bjo.38.7.397 – ident: CIT0066 doi: 10.1097/IAE.0000000000001685 – ident: CIT0023 doi: 10.1056/NEJMoa1007374 – ident: CIT0083 doi: 10.1097/ICU.0b013e328309f1a5 – ident: CIT0026 doi: 10.1016/S0161-6420(87)33255-5 – ident: CIT0091 doi: 10.1016/S0021-5155(03)00088-1 – ident: CIT0107 doi: 10.1001/archopht.124.1.24 – ident: CIT0081 doi: 10.1016/S0161-6420(94)31362-5 – volume: 7 start-page: 200 issue: 3 year: 2018 ident: CIT0090 publication-title: Asia-Pac J Ophthalmol – ident: CIT0009 doi: 10.1016/S0140-6736(95)92475-2 – volume: 97 start-page: 821 year: 1990 ident: CIT0100 publication-title: The Anatomic and Visual Results of Vitreous Surgery Ophthalmology – ident: CIT0119 doi: 10.2353/ajpath.2007.061237 – ident: CIT0103 doi: 10.1016/j.ophtha.2014.11.004 – ident: CIT0108 doi: 10.1001/archophthalmol.2011.229 – ident: CIT0075 doi: 10.1016/S0161-6420(85)34038-1 – ident: CIT0044 doi: 10.1097/IAE.0000000000000604 – ident: CIT0114 doi: 10.1016/S0161-6420(90)32637-4 – ident: CIT0064 doi: 10.1007/s10384-015-0401-5 – ident: CIT0125 doi: 10.1016/S0161-6420(03)00831-5 – ident: CIT0012 doi: 10.1001/jamaophthalmol.2017.2195 – volume: 118 start-page: 526 issue: 2 year: 2008 ident: CIT0030 publication-title: J Clin Invest – ident: CIT0118 doi: 10.1097/00006982-200104000-00001 – ident: CIT0095 doi: 10.1016/j.ophtha.2016.04.033 – ident: CIT0117 doi: 10.1016/j.ophtha.2018.11.001 – ident: CIT0082 doi: 10.1016/j.ophtha.2004.05.030 – ident: CIT0018 doi: 10.1136/archdischild-2016-310532 – ident: CIT0028 doi: 10.1172/JCI17808 – ident: CIT0050 doi: 10.1001/jamaophthalmol.2014.2772 – ident: CIT0116 doi: 10.1097/IAE.0000000000001725 – ident: CIT0101 doi: 10.1016/S0161-6420(79)35436-7 – volume: 31 start-page: 374 issue: 5 year: 2000 ident: CIT0079 publication-title: Ophthalmic Surg Lasers doi: 10.3928/1542-8877-20000901-04 – volume: 53 start-page: S89 issue: 2 year: 2016 ident: CIT0004 publication-title: Indian Pediatr – ident: CIT0047 doi: 10.1001/jamaophthalmol.2017.1055 – ident: CIT0089 doi: 10.1097/IAE.0000000000000128 – ident: CIT0052 doi: 10.1001/archophthalmol.2012.592 – ident: CIT0032 doi: 10.1016/j.jpeds.2018.10.033 – ident: CIT0077 doi: 10.1016/S0161-6420(92)31978-5 – ident: CIT0033 doi: 10.1023/A:1022474120512 – ident: CIT0001 doi: 10.1016/j.earlhumdev.2007.11.009 – ident: CIT0006 doi: 10.1016/S0140-6736(12)61856-X – ident: CIT0015 doi: 10.1056/NEJMra1208129 – ident: CIT0027 doi: 10.1038/nm1095-1024 – ident: CIT0096 doi: 10.1016/j.ajo.2006.05.048 – ident: CIT0099 doi: 10.1097/IAE.0b013e31815e986c – ident: CIT0041 doi: 10.1016/S0161-6420(01)01017-X – ident: CIT0002 doi: 10.1136/bjophthalmol-2014-305561 – ident: CIT0078 doi: 10.1097/00006982-200410000-00011 – ident: CIT0061 doi: 10.1097/IAE.0000000000002172 – ident: CIT0115 doi: 10.1016/j.ophtha.2017.11.009 – ident: CIT0110 doi: 10.1001/archopht.1993.01090030063040 – ident: CIT0021 doi: 10.1001/jamaophthalmol.2017.2069 – ident: CIT0098 doi: 10.1097/01.iae.0000244286.56133.09 – start-page: 67 volume-title: Pediatric retinal diseases: medical and surgical approaches year: 2005 ident: CIT0124 – ident: CIT0048 doi: 10.1097/ICU.0000000000000360 – ident: CIT0065 doi: 10.1097/ICB.0000000000000221 – ident: CIT0031 doi: 10.1073/pnas.0702031104 – ident: CIT0024 doi: 10.1016/j.ophtha.2014.07.050 – ident: CIT0120 doi: 10.1038/s41598-018-20278-4 – ident: CIT0043 doi: 10.1016/j.jaapos.2012.10.025 – ident: CIT0109 doi: 10.1136/bjophthalmol-2016-309198 – ident: CIT0062 doi: 10.1097/IAE.0b013e3182993d5f – ident: CIT0029 doi: 10.1016/j.jaapos.2008.02.001 – ident: CIT0040 doi: 10.1001/archopht.1988.01060130517027 – ident: CIT0045 doi: 10.1542/peds.2018-3061 – ident: CIT0102 doi: 10.1016/j.ophtha.2005.03.031 – ident: CIT0008 doi: 10.1056/NEJM199204163261603 – ident: CIT0094 doi: 10.1097/01.iae.0000244257.60524.89 – ident: CIT0097 doi: 10.1097/IAE.0000000000001779 – ident: CIT0105 doi: 10.1136/bjophthalmol-2011-301353 – ident: CIT0019 doi: 10.1159/000330174 – ident: CIT0057 doi: 10.1016/j.ajo.2011.07.005
SSID	ssj0053842
Score	2.3261924
SecondaryResourceType	review_article
Snippet	Introduction: Retinopathy of prematurity (ROP) is a leading cause of childhood blindness worldwide. Areas covered: Recent methods to identify and manage... Retinopathy of prematurity (ROP) is a leading cause of childhood blindness worldwide. Recent methods to identify and manage treatment-warranted vascularly... Retinopathy of prematurity (ROP) is a leading cause of childhood blindness worldwide.INTRODUCTIONRetinopathy of prematurity (ROP) is a leading cause of...
SourceID	pubmedcentral proquest pubmed crossref informaworld
SourceType	Open Access Repository Aggregation Database Index Database Enrichment Source Publisher
StartPage	73
SubjectTerms	angiogenesis laser lens-sparing retinal detachment Retinopathy of prematurity (ROP) scleral buckle stage 4 or 5 ROP surgical outcomes vascular endothelial growth factor inhibitors (anti-VEGF) vitrectomy
Title	A review of treatment for retinopathy of prematurity
URI	https://www.tandfonline.com/doi/abs/10.1080/17469899.2019.1596026 https://www.ncbi.nlm.nih.gov/pubmed/31762784 https://www.proquest.com/docview/2317967488 https://pubmed.ncbi.nlm.nih.gov/PMC6874220
Volume	14
WOSCitedRecordID	wos000470063900001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
hasFullText	1
inHoldings	1
isFullTextHit
isPrint
journalDatabaseRights	– providerCode: PRVAWR databaseName: Taylor & Francis Online Journals customDbUrl: eissn: 1746-9902 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0053842 issn: 1746-9899 databaseCode: TFW dateStart: 20061001 isFulltext: true titleUrlDefault: https://www.tandfonline.com providerName: Taylor & Francis
link	http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1LT8MwDLZgQogL78d4TEXi2rG0XZMcJ8TEASYOQ-xWpWkiJqFuWjck_j12H9OKQDvAsUpdJU4cO439fQA3Qcw8ilxdiebgoiV6rrS-dbU2MuY-QV7lrCWPfDAQo5F8LrMJszKtks7QtgCKyPdqMm4VZ1VG3C0G0UR7SGUmTLbRHxONEu7C6PqJw2DYf632YrTmnD6HJFwSqWp4fvtKzTvVsEt_ikC_J1KueKb-3j-MaR92y7DU6RXr6AA2THoI20_lxfsRBD2nKHJxJtZZJqc72HGHyiDTCTEbf1LjdEYosDkn3jG89O-Hdw9uSbjgajy3zF3PcBEnKjQJ84XxbOxzFStuGccRKoPBIcEnhkxZoa0QkgkVWp54iWYJxlnCP4FGOknNGTgd5aNBx1IrJvEEqDAOi7vKk6HqJrqjgiYElaIjXaKREynGe8RK0NJKIxFpJCo10oT2UmxawHGsE5CrsxjN8_8gtiAtifw1stfVlEdodHSTolIzWWQRBsVcEk2LaMJpsQSW3cGmkG5zm8Bri2P5AgF611vS8VsO7B0KHnhe5_wPfb6AHXrMs-SCS2jMZwtzBVv6Yz7OZi3Y5CPRyk3kC9sNCxs
linkProvider	Taylor & Francis
linkToHtml	http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1LT8MwDLZ4Cbjwfoxnkbh2LG3XJEeEmECMnYbgFqVpIiahbtoGEv8eu49pQ6Ad4Jy6Spw4dhL7-wAuo4QFFLn6Es3BR0sMfOlC5xtjZcJDgrzKWUvavNMRLy9yuhaG0irpDO0KoIh8rybjpsvoKiXuCqNo4j2kOhMm6-iQiUdpEZab6GtplXdbz9VujPacE-iQiE8yVRXPb7-Z8U8z6KU_xaDfUymnfFNr8z9GtQUbZWTqXRdLaRsWbLYDq4_l2_suRNdeUefi9Z03yU_3sOceVUJmfSI3_qTGwZCAYHNavD14at12b-78knPBN3h0GfuB5SJJdWxTFgobuCTkOtHcMY5D1BbjQ0JQjJl2wjghJBM6djwNUsNSDLVEuA9LWT-zh-A1dIg2nUijmcRDoMZQLGnqQMa6mZqGjmoQVZpWpgQkJ16MN8VK3NJKI4o0okqN1KA-ERsUiBzzBOT0NKpxfhXiCt4SFc6RvajmXKHd0WOKzmz_faQwLuaSmFpEDQ6KNTDpDjbF9KBbAz6zOiYfEKb3bEvWe82xvWPBoyBoHP2hz-ewdtd9bKv2fefhGNapKU-ai05gaTx8t6ewYj7GvdHwLLeUL3Q0Dl4
linkToPdf	http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3JTsMwEB2xqeLCvpQ1SFxT6iTE9hEBFQioOBTRm-U4tqiE0qoLEn_PTJaKIhAHOE8mcmyP_RzPvAdwGiUsIOTqSwwHHyMx8KULnW-MlQkPifIqVy255-226HblY5lNOCrTKukM7QqiiHytpuAepK7KiDtDEE2yh1RmwmQD92OSUZqHRYTOMZ2_Oq3najHGcM71c8jFJ5-qiOen18xsTzPkpd9B0K-ZlJ-2ptbqP3zUGqyUuNS7KCbSOszZbANqD-XN-yZEF15R5eL1nTfNTvew4R7VQWZ9kjZ-J-NgSDSwuSjeFjy1rjuXN36puOAbPLiM_cBykaQ6tikLhQ1cEnKdaO4Yxy_UFtEh8SfGTDthnBCSCR07ngapYSkCLRFuw0LWz-wueE0dYkQn0mgm8QioEYgl5zqQsT5PTVNHdYiqjlampCMnVYxXxUrW0qpHFPWIKnukDo2p26Dg4_jNQX4eRTXOf4S4QrVEhb_4nlRDrjDq6CpFZ7Y_GSlExVySTouow04xBabNQVNM17l14DOTY_oAMXrPWrLeS87sHQseBUFz7w9tPoba41VL3d-27_ZhmSx5xlx0AAvj4cQewpJ5G_dGw6M8Tj4AM9MNDw
openUrl	ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=A+review+of+treatment+for+retinopathy+of+prematurity&rft.jtitle=Expert+review+of+ophthalmology&rft.au=Hansen%2C+Eric+D&rft.au=Hartnett%2C+M+Elizabeth&rft.date=2019-03-04&rft.issn=1746-9899&rft.volume=14&rft.issue=2&rft.spage=73&rft_id=info:doi/10.1080%2F17469899.2019.1596026&rft.externalDBID=NO_FULL_TEXT
thumbnail_l	http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1746-9899&client=summon
thumbnail_m	http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1746-9899&client=summon
thumbnail_s	http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1746-9899&client=summon